Loading…
Immix Biopharma, Inc. is projected to rise to $18.72 by 2027, a +69% move from its current price of $11.11. IMMX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.66 | $11.12 | $11.61 | +0.12% |
| Jul 14 | $10.49 | $11.14 | $11.83 | +0.25% |
| Jul 15 | $10.36 | $11.15 | $12.00 | +0.37% |
| Jul 16 | $10.26 | $11.16 | $12.15 | +0.49% |
| Jul 17 | $10.17 | $11.18 | $12.29 | +0.62% |
| Jul 18 | $10.09 | $11.19 | $12.42 | +0.74% |
| Jul 19 | $10.02 | $11.21 | $12.54 | +0.87% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.02 | $11.21 | $12.54 | +0.87% |
| Week 2 | $9.64 | $11.30 | $13.25 | +1.74% |
| Week 3 | $9.39 | $11.40 | $13.85 | +2.62% |
| Week 4 | $9.19 | $11.50 | $14.40 | +3.51% |
| Week 5 | $9.02 | $11.60 | $14.91 | +4.40% |
| Week 6 | $8.89 | $11.70 | $15.41 | +5.31% |
| Week 7 | $8.77 | $11.80 | $15.89 | +6.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Immix Biopharma, Inc. (IMMX) is a healthcare company described as a clinical-stage biopharmaceutical business that develops chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The lead product is NXC-201 for relapsed/refractory AL Amyloidos.
Immix Biopharma was incorporated in 2012 and is headquartered in Los Angeles, California.
Immix Biopharma, Inc. trades as IMMX and is currently priced at $11.00, with a market capitalization of $783.09M. It ranks 2726 by market cap.
The near-term price picture is framed by a 30-day range of $8.17 to $14.82, with a current setup of support at $7.87 and resistance at $12.02.
The stock shows high volatility, with annualized volatility at 90%.
The forecast path suggests a shift from NEUTRAL in 2026 to BULLISH thereafter, with 2027 avg $18.85, 2028 avg $22.65, 2029 avg $24.80, 2030 avg $25.62, 2040 avg $109.95 and 2050 avg $216.21, accompanied by rising ROIs (e.g., 71.4% in 2027 up to 1865.5% in 2050).
A major floor 44.3% below — a decisive break under it would weaken the trend.
The nearest floor, 29.2% below — buyers have tended to step in here.
The nearest ceiling, 8.2% above — a clean break opens room to run.
A major ceiling 30.4% above — clearing it would confirm fresh momentum.
Key IMMX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMMX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.13 | Sell | $11.00 | Buy |
| MA 10 | $10.66 | Buy | $10.67 | Buy |
| MA 20 | $9.87 | Buy | $10.14 | Buy |
| MA 50 | $9.40 | Buy | $9.55 | Buy |
| MA 100 | $9.30 | Buy | $8.82 | Buy |
| MA 200 | $6.87 | Buy | $7.34 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.63 | Neutral |
| Stoch RSI (14) | 31.84 | Neutral |
| CCI (20) | 100.91 | Buy |
| Williams %R (14) | -34.73 | Info |
| MACD (12,26,9) | 0.16 | Buy |
| ROC (12) | 12.11 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 65.27 | Neutral |
| TRIX (15) | 0.66 | Buy |
| Awesome (5,34) | 1.82 | Buy |
| Ultimate (7,14,28) | 62.87 | Neutral |
| Momentum (10) | 1.39 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 11.48 | Sell |
| ADX (14) | 20.73 | Buy |
| ATR (14) | 0.39 | Info |
The 30-day technical picture is BULLISH overall, with RSI(14) at 60 and trend signals supported by SMA50 at $9.32 and SMA200 at $6.78.
Near-term support sits at $7.87 and resistance at $12.02, while the 30-day range spans $8.17 to $14.82. These levels frame room for movement toward the indicated resistance while remaining above the support.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.44 | $11.11 | $18.53 | 0% | Neutral | |
| $14.14 | $18.72 | $26.63 | +69% | Bullish | |
| $16.15 | $22.39 | $33.60 | +102% | Bullish | |
| $17.02 | $24.54 | $38.36 | +121% | Bullish | |
| $17.28 | $25.80 | $41.73 | +132% | Bullish | |
| $20.17 | $31.10 | $51.82 | +180% | Bullish | |
| $24.75 | $39.34 | $67.30 | +254% | Bullish | |
| $30.89 | $50.53 | $88.51 | +355% | Bullish | |
| $33.93 | $57.08 | $102.17 | +414% | Bullish | |
| $35.16 | $60.77 | $110.97 | +447% | Bullish | |
| $55.52 | $108.90 | $215.97 | +880% | Bullish | |
| $97.43 | $216.52 | $482.95 | +18.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.44 | $11.11 | $13.39 | +0.00% |
| August 2026 | $9.79 | $11.72 | $14.54 | +5.52% |
| September 2026 | $10.26 | $12.43 | $15.68 | +6.03% |
| October 2026 | $10.16 | $12.43 | $15.91 | +0.01% |
| November 2026 | $10.41 | $12.84 | $16.63 | +3.30% |
| December 2026 | $11.40 | $14.16 | $18.53 | +10.27% |
Click any year to see its month-by-month IMMX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IMMX price prediction for 2026 points to an average of $11.11 (low $4.44, high $18.53) — a potential gain of 0% on today's $11.11. Price action looks broadly range-bound.
In 2027, IMMX is projected to trade between $14.14 and $26.63, averaging $18.72 — a potential gain of +69% from today's $11.11. That is up +69% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Immix Biopharma, Inc.'s 2028 outlook centres on $22.39, within a $16.15 to $33.60 range. That is up +20% on the projected 2027 average. That marks a +102% change versus current levels. Momentum favours further upside here.
By 2029, IMMX could reach as high as $38.36, with a base case around $24.54 and support toward $17.02 — roughly +121% from $11.11. Buyers look set to stay in control over this stretch.
Expect IMMX to range from $17.28 to $41.73 through 2030. The $25.80 average target implies a +132% move from current prices. That is up +5% on the projected 2029 average. Momentum favours further upside here.
The IMMX price prediction for 2031 points to an average of $31.10 (low $20.17, high $51.82) — a potential gain of +180% on today's $11.11. Buyers look set to stay in control over this stretch.
In 2032, IMMX is projected to trade between $24.75 and $67.30, averaging $39.34 — a potential gain of +254% from today's $11.11. That is up +27% on the projected 2031 average. Momentum favours further upside here.
Immix Biopharma, Inc.'s 2033 outlook centres on $50.53, within a $30.89 to $88.51 range. That is up +28% on the projected 2032 average. That marks a +355% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, IMMX could reach as high as $102.17, with a base case around $57.08 and support toward $33.93 — roughly +414% from $11.11. Momentum favours further upside here.
Expect IMMX to range from $35.16 to $110.97 through 2035. The $60.77 average target implies a +447% move from current prices. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The IMMX price prediction for 2040 points to an average of $108.90 (low $55.52, high $215.97) — a potential gain of +880% on today's $11.11. Momentum favours further upside here.
In 2050, IMMX is projected to trade between $97.43 and $482.95, averaging $216.52 — a potential gain of +18.5x from today's $11.11. That is up +99% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IMMX today (≈ 90.009001 IMMX) could be worth
$19,488.56
+$18,488.56 (+1849%) by 2050 · US Dollar
Based on the average projected IMMX price of $216.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMMXwould be worth at today's price.
$1,000 invested in IMMX on Jul 10, 2025 (≈ 369.003685 IMMX) would be worth
$4,099.63
+$3,099.63 (+310.0%) today · 4.10× · US Dollar
Based on a IMMX entry price of $2.71 vs. today's $11.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.34 | $1,074.47 | +7.4% |
| 1 month ago | $8.18 | $1,358.19 | +35.8% |
| 3 months ago | $9.26 | $1,199.78 | +20.0% |
| 6 months ago | $4.44 | $2,502.25 | +150.2% |
| 1 year ago | $2.71 | $4,099.63 | +310.0% |
| All time (4.6y) ago | $3.67 | $3,027.25 | +202.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMMX forecast.
Our base-case forecast reaches $22.00 around 2028.
Implied market cap at $22.00: $1.57B
The multi-year forecast shows bullish sentiment across the horizon, with average prices rising from 2027 through 2050: 2027 avg $18.85, 2028 avg $22.65, 2029 avg $24.80, 2030 avg $25.62, 2031 avg $31.07, 2032 avg $39.27, 2033 avg $50.57, 2034 avg $57.90, 2035 avg $61.43, 2040 avg $109.95, and 2050 avg $216.21.
Corresponding ROIs rise from 0% in 2026 to 71.4% in 2027, 105.9% in 2028, 125.5% in 2029, 132.9% in 2030, 182.4% in 2031, 257% in 2032, 359.7% in 2033, 426.3% in 2034, 458.4% in 2035, 899.5% in 2040, and 1865.5% in 2050. These figures illustrate substantial upside potential under the provided projections.
These are estimates and not guarantees. Actual results depend on multiple factors, and investors should consider the inherent uncertainty in long-term biotech forecasts.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $25.62, with a min of $16.83 and a max of $42.21, and an estimated ROI of 132.9%; sentiment is BULLISH.
The forecast includes a path from neutral in 2026 to bullish from 2027 onward, with average prices rising to $25.62 by 2030 and to $216.21 by 2050, and ROIs reaching up to 1865.5%. These are estimates and not guarantees.
Yes. The 2040 maximum is $223.89 and the 2050 maximum is $497.14, indicating potential to exceed $100 under the projected path.
Current price is $11.00 and market cap is $783.09M. The asset ranks 2726.
The 30-day picture is bullish with RSI(14) at 60. The SMA50 is $9.32 and the SMA200 is $6.78. The 30-day range is $8.17–$14.82, with support at $7.87 and resistance at $12.02.
Immix Biopharma, Inc. Community Discussion
0Share your Immix Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.